Audrey Mauguen

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors

R. Blasberg, B. Beattie, A. Lassman, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer

Jason S. Lewis, S. Modi, G. Ulaner, 2024, The Journal of Nuclear Medicine.

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

J. Humm, A. Ho, R. Ghossein, 2023, European journal of nuclear medicine and molecular imaging.

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.

Jason S. Lewis, H. Schoder, N. Rekhtman, 2024, The Lancet. Oncology.